Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review

被引:13
作者
He, Yan-Fei [1 ]
Ouyang, Jing [2 ]
Hu, Xiao-Dong [3 ]
Wu, Ni [1 ]
Jiang, Zhi-Gang [4 ]
Bian, Ning [1 ]
Wang, Jie [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Hlth Management Ctr, Med Ctr 6, 6 Fu Cheng Rd, Beijing 100048, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Casualty Management Sect, Beijing 100048, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Dept Endocrinol, Beijing 100048, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Hlth Management Ctr, Med Ctr 6, Beijing 100048, Peoples R China
关键词
COVID-19; Vaccination; Diabetes mellitus; Antibody; Blood glucose; Immune response; IMMUNE-RESPONSE; SEX-DIFFERENCES; OBESITY; IMMUNOGENICITY; TYPE-1; IMPACT; SAFETY; BLIND; RISK;
D O I
10.4239/wjd.v14.i6.892
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUNDCoronavirus disease 2019 (COVID-19) is one of the current global public health threats and vaccination is the most effective tool to reduce the spread and decrease the severity of COVID-19. Diabetes is one of the important chronic diseases threatening human health and is a common comorbidity of COVID-19. What is the impact of diabetes on the immunization effect of COVID-19 vaccination? Conversely, does vaccination against COVID-19 exacerbate the severity of pre-existing diseases in patients with diabetes? There are limited and conflicting data on the interrelationship between diabetes and COVID-19 vaccination.AIMTo explore the clinical factors and possible mechanisms underlying the interaction between COVID-19 vaccination and diabetes.METHODSWe conducted a comprehensive search of PubMed, MEDLINE, EMBASE, and Reference Citation Analysis (https://www.referencecitationanalysis.com) online databases, and medRxiv and bioRxiv gray literature using the keywords "SARS-CoV-2", "COVID-19", "vaccine", "vaccination", "antibody", and "diabetes" individually or in combination, with a cut-off date of December 2, 2022. We followed inclusion and exclusion criteria and after excluding duplicate publications, studies with quantifiable evidence were included in the full-text review, plus three manually searched publications, resulting in 54 studies being included in this review.RESULTSA total of 54 studies were included, from 17 countries. There were no randomized controlled studies. The largest sample size was 350963. The youngest of the included samples was 5 years old and the oldest was 98 years old. The included population included the general population and also some special populations with pediatric diabetes, hemodialysis, solid organ transplantation, and autoimmune diseases. The earliest study began in November 2020. Thirty studies discussed the effect of diabetes on vaccination, with the majority indicating that diabetes reduces the response to COVID-19 vaccination. The other 24 studies were on the effect of vaccination on diabetes, which included 18 case reports/series. Most of the studies concluded that COVID-19 vaccination had a risk of causing elevated blood glucose. A total of 12 of the 54 included studies indicated a "no effect" relationship between diabetes and vaccination.CONCLUSIONThere is a complex relationship between vaccination and diabetes with a bidirectional effect. Vaccination may contribute to the risk of worsening blood glucose in diabetic patients and diabetic patients may have a lower antibody response after vaccination than the general population.
引用
收藏
页码:892 / 918
页数:27
相关论文
共 107 条
  • [1] Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM Study
    Aberer, Felix
    Moser, Othmar
    Aziz, Faisal
    Sourij, Caren
    Ziko, Haris
    Lenz, Jacqueline
    Abbas, Farah
    Obermayer, Anna M.
    Kojzar, Harald
    Pferschy, Peter N.
    Mueller, Alexander
    Unteregger, Christina
    Leitner, Marlies
    Banfic, Tamara
    Eckstein, Max L.
    Wachsmuth, Nadine
    Kaser, Susanne
    Mader, Julia K.
    Tripolt, Norbert J.
    Sourij, Harald
    [J]. DIABETES CARE, 2022, 45 (02) : E24 - E26
  • [2] Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses
    Abu-Raddad, Laith J.
    Chemaitelly, Hiam
    Yassine, Hadi M.
    Benslimane, Fatiha M.
    Al Khatib, Hebah A.
    Tang, Patrick
    Malek, Joel A.
    Coyle, Peter
    Ayoub, Houssein H.
    Al Kanaani, Zaina
    Al Kuwari, Einas
    Jeremijenko, Andrew
    Kaleeckal, Anvar Hassan
    Latif, Ali Nizar
    Shaik, Riyazuddin Mohammad
    Abdul Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al Kuwari, Mohamed Ghaith
    Al Romaihi, Hamad Eid
    Al-Thani, Mohamed H.
    Al Khal, Abdullatif
    Butt, Adeel A.
    Bertollini, Roberto
    [J]. JOURNAL OF TRAVEL MEDICINE, 2021, 28 (07)
  • [3] COVID-19 Vaccine and Hyperosmolar Hyperglycemic State
    Abu-Rumaileh, Mohammed A.
    Gharaibeh, Ahmad M.
    Gharaibeh, Naser Eddin
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (03)
  • [4] Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients-a prospective cohort study
    Agur, Timna
    Ben-Dor, Naomi
    Goldman, Shira
    Lichtenberg, Shelly
    Herman-Edelstein, Michal
    Yahav, Dafna
    Rozen-Zvi, Benaya
    Zingerman, Boris
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (07) : 1347 - 1349
  • [5] Comparison of the safety and immunogenicity of the BNT-162b2 vaccine and the ChAdOx1 vaccine for solid organ transplant recipients: a prospective study
    Ajlan, Aziza A.
    Ali, Tariq
    Aleid, Hassan
    Almeshari, Khalid
    DeVol, Edward
    Alkaff, Morad Ahmed
    Fajji, Layal
    Alali, Ali
    Halabi, Dani
    Althuwaidi, Sahar
    Alghamdi, Saad
    Ullah, Asad
    Alrajhi, Abdulrahman
    Bzeizi, Khalid
    Almaghrabi, Reem
    Marquez, Kris Ann Hervera
    Elmikkaoui, Bilal
    Albogumi, Eid
    Aldakhil, Haifa
    Al-Awwami, Moheeb
    Broering, Dieter C.
    [J]. BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [6] COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
    Al-kuraishy, Hayder M.
    Al-Gareeb, Ali I.
    Alblihed, M.
    Guerreiro, Susana G.
    Cruz-Martins, Natalia
    Batiha, Gaber El-Saber
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [7] Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination
    Ali, Hamad
    Alterki, Abdulmohsen
    Sindhu, Sardar
    Alahmad, Barrak
    Hammad, Maha
    Al-Sabah, Salman
    Alghounaim, Mohammad
    Jamal, Mohammad H.
    Aldei, Ali
    Mairza, Mohammad J.
    Husain, Maitham
    Deverajan, Sriraman
    Ahmad, Rasheed
    Cherian, Preethi
    Alkhairi, Irina
    Alkandari, Abdullah
    Abubaker, Jehad
    Abu-Farha, Mohamed
    Al-Mulla, Fahd
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [8] Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers
    Alqassieh, Rami
    Suleiman, Aiman
    Abu-Halaweh, Sami
    Santarisi, Abeer
    Shatnawi, Omar
    Shdaifat, Lara
    Tarifi, Amjed
    Al-Tamimi, Mohammad
    Al-Shudifat, Abdel-Ellah
    Alsmadi, Heba
    Al Sharqawi, Ahmed
    Alnawaiseh, Hadeel
    Anasweh, Yara
    Domaidah, Farah Abo
    Abu Jaber, Haneen
    Al-Zarir, Mohammad Rashid
    Bsisu, Isam
    [J]. VACCINES, 2021, 9 (11)
  • [9] COVID-19 in people with diabetes: understanding the reasons for worse outcomes
    Apicella, Matteo
    Campopiano, Maria Cristina
    Mantuano, Michele
    Mazoni, Laura
    Coppelli, Alberto
    Prato, Stefano Del
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (09) : 782 - 792
  • [10] Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
    Aydogan, Berna Imge
    Unluturk, Ugur
    Cesur, Mustafa
    [J]. ENDOCRINE, 2022, 78 (01) : 42 - 46